Suchergebnisse - "Gaya, Anna"

PubPharm (60)

1

Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria

enthalten in: The New England journal of medicine | 2024

von Peffault de Latour, R. | Röth, A. | Kulasekararaj, A. | +50

2

Results of a phase 1/2 study of cemdisiran in healthy subjects and patients with paroxysmal nocturnal hemoglobinuria

enthalten in: EJHaem | 2023

von Gaya, A. | Munir, T. | Urbano-Ispizua, A. | +8

3

Cloudy fluid, cloudy diagnosis

enthalten in: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis | 2022

von Risco-Zevallos, J. | Piñeyroa, J. | Rodríguez-Espinosa, D. | +6

4

Pegcetacoplan : climbing up the complement cascade

enthalten in: The Lancet. Haematology | 2022

von Gaya, A.

5

Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID-19

enthalten in: Haematologica | 2022

von Garcia-Vidal, C. | Puerta-Alcalde, P. | Mateu, A. | +18

6

One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab

enthalten in: European journal of haematology | 2021

von Kulasekararaj, A. | Hill, A. | Langemeijer, S. | +15

7

Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021

von Camprubí, D. | Gaya, A. | Marcos, M. | +7

8

One‐year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab

enthalten in: European Journal of Haematology | 2021

von Kulasekararaj, A. | Hill, A. | Langemeijer, S. | +15

9

Comparison of one-catheter strategy versus conventional two-catheter strategy on the volume of radiological contrast and diagnostic coronary catheterization performance by transradial access : A systematic review and meta-analysis of randomized clinical trials

enthalten in: Archivos de cardiologia de Mexico | 2020

von Fernández-Rodríguez, D. | Costa-Mateu, J. | Rivera, K. | +7

10

Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria

enthalten in: PloS one | 2020

von Peipert, J. | Kulasekararaj, A. | Gaya, A. | +17

1
2
3
4
5
6
Nächster »
[6]